Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 12/20 | 0.36 |
| ▸ | HTR6 | P50406 | 5/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 3/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 3/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HTR1A | P08908 | 4/20 | 0.35 |
| ▸ | DRD2 | P14416 | 4/20 | 0.35 |
| ▸ | HTR2A | P28223 | 4/20 | 0.35 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17577086 | 0.98 | CA1 (0.39) | CA1CA2CA9CXCR4HTR7 | |
| SCHEMBL18062209 | 0.95 | CA1 (0.41) | CA1CA2CA9CXCR4HTR7 | |
| SCHEMBL9528515 | 0.95 | CA9 (0.43) | CA1CA2CA9CXCR4HTR7 | |
| SCHEMBL22931512 | 0.91 | HRH3 (0.44) | CA1CA2CA9CXCR4HTR7 | |
| SCHEMBL430482 | 0.89 | CXCR4 (0.40) | CA1CA2CA9CXCR4CA12 | |
| SCHEMBL17826472 | 0.88 | LMNA (0.45) | CA1CA2CA9TLR8 | |
| SCHEMBL17577101 | 0.88 | TLR8 (0.36) | CA1CA2CA9CXCR4HTR7 | |
| SCHEMBL18680424 | 0.88 | CYP1A2 (0.44) | CA1CA2CA9NPSR1TLR8 | |
| SCHEMBL14725030 | 0.86 | TLR8 (0.51) | CA1CA2CA9TLR8 | |
| SCHEMBL18466743 | 0.85 | HSP90AA1 (0.37) | CA1CA2CA9CXCR4HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11440304-B2 | Laminate and its production method | AGC Inc. (JP) | 2022-09-13 | — | — | US | disclosed |
| EP-3561151-B1 | COMPOSITION FOR FORMING COATING, PRODUCTION METHOD FOR SURFACE-TREATED METAL MEMBER, AND PRODUCTION METHOD FOR METAL-RESIN COMPOSITE | MEC CO LTD (JP) | 2021-02-03 | — | — | EP | disclosed |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | Mori, Kunio (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9790242-B2 | Surface treatment method, surface treatment agent, and novel compound | Mori, Kunio (JP) | 2017-10-17 | — | — | US | disclosed |
| WO-2016036847-A9 | SYNTHETIC POLYMERS AND METHODS OF MAKING AND USING THE SAME | BATTELLE MEMORIAL INSTITUTE (US) | 2017-04-20 | — | — | WO | disclosed |
| US-20170088671-A1 | SYNTHETIC POLYMERS AND METHODS OF MAKING AND USING THE SAME | BATTELLE MEMORIAL INSTITUTE (US) | 2017-03-30 | — | — | US | disclosed |
| US-9562137-B2 | Synthetic polymers and methods of making and using the same | BATTELLE MEMORIAL INSTITUTE (US) | 2017-02-07 | — | — | US | disclosed |
| WO-2016036847-A1 | SYNTHETIC POLYMERS AND METHODS OF MAKING AND USING THE SAME | BATTELLE MEMORIAL INSTITUTE (US) | 2016-03-10 | — | — | WO | disclosed |
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | Mori, Kunio (JP) | 2015-06-04 | — | — | US | disclosed |
| US-9023139-B2 | Coloring composition, ink for inkjet recording and inkjet recording method | FUJIFILM CORPORATION (JP) | 2015-05-05 | — | — | US | disclosed |
| EP-2821444-A1 | COLORED COMPOSITION, INKJET RECORDING INK, AND INKJET RECORDING METHOD | Fujifilm Corporation (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-20140368573-A1 | COLORING COMPOSITION, INK FOR INKJET RECORDING AND INKJET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| US-8845760-B2 | Compound having multimer structure of xanthene derivative, coloring composition, ink for inkjet recording, method of inkjet recording, color filter, and color toner | FUJIFILM CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20140176653-A1 | NOVEL COMPOUND HAVING MULTIMER STRUCTURE OF XANTHENE DERIVATIVE, COLORING COMPOSITION, INK FOR INKJET RECORDING, METHOD OF INKJET RECORDING, COLOR FILTER, AND COLOR TONER | FUJIFILM CORPORATION (JP) | 2014-06-26 | — | — | US | disclosed |
| US-20140176653-A1 | NOVEL COMPOUND HAVING MULTIMER STRUCTURE OF XANTHENE DERIVATIVE, COLORING COMPOSITION, INK FOR INKJET RECORDING, METHOD OF INKJET RECORDING, COLOR FILTER, AND COLOR TONER | FUJIFILM CORPORATION (JP) | 2014-06-26 | — | — | US | disclosed |
| EP-0179408-B1 | AMIDOALKYL MELAMINES AND AMINOALKYL MELAMINES, AND PROCESS FOR THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1993-09-08 | — | — | EP | disclosed |
| US-4670558-A | POLYURETHANE INTERMEDIATES | BASF AKTIENGESELLSCHAFT (DE) | 1987-06-02 | — | — | US | disclosed |
| EP-0179408-A2 | Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation | BASF Aktiengesellschaft (DE) | 1986-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152124-A1 | SURFACE TREATMENT METHOD, SURFACE TREATMENT AGENT, AND NOVEL COMPOUND | EPCAM, ITGAM, MET | CA1 486/4885CA2 1279/4885CA9 2898/4885 |
| US-20170334933-A1 | SURFACE TREATMENT AGENT AND NOVEL COMPOUND | EPCAM, MET, ITGAM | CA1 159/4885CA2 860/4885CA9 1680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.